Counting down to World Cancer Day 04 February 2022 #CloseTheCareGap
The next 3-year World Cancer Day (WCD) campaign themed Close [...]
A total of 18 VHIO researchers received grants and fellowships in 2021
For yet another year, researchers from the [...]
Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of cholangiocarcinoma patients
VHIO led study supports the integration of [...]
Novel microprotein unmasked as a regulator of neural differentiation & neurite formation via calcium dynamics
High-throughput RNA sequencing studies have led to [...]
Emerging approaches for treating gastroesophageal adenocarcinoma: the pitfalls, progress & promise ahead
According to a recent report (1) gastric cancer (GC) [...]
VHIO ‘on the ground’ at ASH 2021: seeking out more effective treatment strategies against B-cell lymphomas
Recently presented at the Annual Meeting of [...]
Elena Garralda’s latest ESMO On target column: delving into dietary effects on tumor metabolism & progression
In her latest ESMO perspectives On target column entitled Food [...]
KEYNOTE-811: pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
Initial findings of the phase III KEYNOTE-811 [...]
A selection of VHIO research highlights at the San Antonio Breast Cancer Symposium 2021
Barcelona, December 14, 2021. During last week’s onsite [...]
